Stability testing of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine: a translational study in UK vaccination centres
Saved in:
Main Authors: | Michael Cross, Marcus Allen, Laila Kudsiova, Alison Lansley, Greg Scutt, Lucas Bowler, Samantha Lippett, Selma Stafford, Michael Tarzi, Michael Okorie |
---|---|
Format: | article |
Language: | EN |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/e099a35244874b35a22cee38c9e33a03 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Neutrophilic urticarial dermatosis following BNT162b2 (Pfizer–BioNTech) COVID‐19 vaccination
by: Akihiro Matsubara, et al.
Published: (2021) -
Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech)
by: Toshiyuki Sumi, et al.
Published: (2021) -
Pfizer-BioNTech and Sinopharm: A Comparative Study on Post-Vaccination Antibody Titers
by: Rami Alqassieh, et al.
Published: (2021) -
Efficacy of Pfizer-BioNTech in SARS-CoV-2 Delta cluster
by: Hannah E. Landsberg, MSN, MPH, et al.
Published: (2022) -
Systemic drug-related intertriginous and flexural exanthema induced by the Pfizer-BioNTech COVID-19 vaccine: A report of 2 cases
by: Josephine Hai, BS, et al.
Published: (2021)